SAN DIEGO – The rapidly expanding therapeutic landscape of glucagon-like peptide-1 (GLP-1) receptor agonists, widely recognized for their transformative impact…
Read More

SAN DIEGO – The rapidly expanding therapeutic landscape of glucagon-like peptide-1 (GLP-1) receptor agonists, widely recognized for their transformative impact…
Read More
The rapidly expanding landscape of drugs designed to mimic glucagon-like peptide-1 (GLP-1), famously exemplified by Ozempic and Wegovy, is increasingly…
Read More